Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Sanofi Pasteur purchases Freeslate’s formulation system
October 2013
SHARING OPTIONS:

SUNNYVALE, Calif.—Sanofi Pasteur, the vaccines division of Sanofi, has purchased Freeslate's Biologics Formulation System, a comprehensive solution for speeding research in vaccine and protein formulation development. The Biologics Formulation System automates sample preparation, sample stressing and formulation analysis, enabling faster development with less API consumption. Based on Freeslate's Core Module 3 automation program, the system combines liquid dispense and controlled heating/cooling/mixing with new automated measurements of pH, viscosity and particle counting.  
 
"We are excited to be selected by a global leader in vaccines and are pleased they recognize the value our tools bring to the advancement of formulation development," said John S. Senaldi, Freeslate's president and CEO. "As demonstrated by the adoption of our systems in Europe and across the globe, combinatorial approaches to vaccine formulation development can significantly accelerate productivity."  
 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.